Australia markets closed

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
254.75+2.73 (+1.08%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 524.87B
Enterprise value 330.32B
Trailing P/E 16.04
Forward P/E 116.47
PEG ratio (5-yr expected) 11.03
Price/sales (ttm)1.78
Price/book (mrq)2.65
Enterprise value/revenue 32.17
Enterprise value/EBITDA 78.44

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 381.38%
S&P500 52-week change 349.51%
52-week high 3259.29
52-week low 3136.38
50-day moving average 3244.29
200-day moving average 3217.00

Share statistics

Avg vol (3-month) 3732.26k
Avg vol (10-day) 3478.32k
Shares outstanding 597.6M
Implied shares outstanding 6N/A
Float 97.06M
% held by insiders 10.59%
% held by institutions 193.85%
Shares short (14 Mar 2021) 41.56M
Short ratio (14 Mar 2021) 41.79
Short % of float (14 Mar 2021) 41.80%
Short % of shares outstanding (14 Mar 2021) 41.59%
Shares short (prior month 11 Feb 2021) 41.56M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 428 Mar 1994
Last split factor 22:1
Last split date 312 May 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020


Profit margin 11.13%
Operating margin (ttm)22.10%

Management effectiveness

Return on assets (ttm)10.13%
Return on equity (ttm)18.35%

Income statement

Revenue (ttm)13.98B
Revenue per share (ttm)143.66
Quarterly revenue growth (yoy)52.00%
Gross profit (ttm)5.01B
Net income avi to common (ttm)1.56B
Diluted EPS (ttm)15.88
Quarterly earnings growth (yoy)313.20%

Balance sheet

Total cash (mrq)1.32B
Total cash per share (mrq)13.53
Total debt (mrq)6.76B
Total debt/equity (mrq)72.03
Current ratio (mrq)1.66
Book value per share (mrq)96.00

Cash flow statement

Operating cash flow (ttm)2.14B
Levered free cash flow (ttm)1.63B